TDAM USA’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
MWNA
TDAM USA's DGX Position: Q4 2019 in Review
TDAM USA sold out of Quest Diagnostics (DGX) in Q4 2019, closing a stake of 5,241 shares — an estimated $561K sold.
TDAM USA first reported a position in DGX in Q2 2013 and held it in 26 quarters. The position peaked at $4.63M in Q2 2013. 712 funds tracked by Wall St. Rank hold DGX as of Q4 2019.
- TDAM USA reported no remaining Quest Diagnostics position as of Q4 2019 after selling out during the quarter.
- TDAM USA sold 5,241 Quest Diagnostics shares in Q4 2019, an estimated $561K.
- TDAM USA first reported a position in Quest Diagnostics in Q2 2013 and held it in 26 quarters.
- TDAM USA's Quest Diagnostics position peaked at $4.63M in Q2 2013.
- 712 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2019.
Based on TDAM USA's 13F filing for Q4 2019, filed 11 Feb 2020.